Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 9, Number 1, January 2011

Free Content Fibrinogen concentrate for management of bleeding
pp. 1-5(5)
Authors: RAHE-MEYER, N.; SØRENSEN, B.

Favourites:
ADD
Favourites:
ADD

Free Content Factor XIII: novel structural and functional aspects
pp. 9-20(12)
Authors: KOMÁROMI, I.; BAGOLY, Z.; MUSZBEK, L.

Favourites:
ADD

Free Content Beware of being caught on the rebound
pp. 21-23(3)
Authors: LORDKIPANIDZÉ, M.; HARRISON, P.

Favourites:
ADD

Free Content Clopidogrel discontinuation and platelet reactivity following coronary stenting
pp. 24-32(9)
Authors: MYLOTTE, D.; PEACE, A. J.; TEDESCO, A. T.; MANGIACAPRA, F.; DICKER, P.; KENNY, D.; FOLEY, D. P.

Favourites:
ADD

Free Content Plasma glutathione peroxidase in pediatric stroke families
pp. 33-38(6)
Authors: NOWAK-GÖTTL, U.; FIEDLER, B.; HUGE, A.; NIEDERSTADT, T.; THEDIECK, S.; SEEHAFER, T.; STOLL, M.

Favourites:
ADD

Free Content A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
pp. 39-48(10)
Authors: VAN STAA, T. P.; SETAKIS, E.; DI TANNA, G. L.; LANE, D. A.; LIP, G. Y. H.

Favourites:
ADD

Free Content High platelet volume and increased risk of myocardial infarction: 39 531 participants from the general population
pp. 49-56(8)
Authors: KLOVAITE, J.; BENN, M.; YAZDANYAR, S.; NORDESTGAARD, B. G.

Favourites:
ADD

Free Content Thrombosis risk and survival in cancer patients with elevated C-reactive protein
pp. 57-63(7)
Authors: KANZ, R.; VUKOVICH, T.; VORMITTAG, R.; DUNKLER, D.; AY, C.; THALER, J.; HASELBÖCK, J.; SCHEITHAUER, W.; ZIELINSKI, C.; PABINGER, I.

Favourites:
ADD
Favourites:
ADD

Free Content Factor V Leiden as a risk factor for preterm birth – a population-based nested case–control study
pp. 71-78(8)
Authors: HILTUNEN, L. M.; LAIVUORI, H.; RAUTANEN, A.; KAAJA, R.; KERE, J.; KRUSIUS, T.; RASI, V.; PAUNIO, M.

Favourites:
ADD

Free Content Is extensive screening for cancer in idiopathic venous thromboembolism warranted?
pp. 79-84(6)
Authors: VAN DOORMAAL, F. F.; TERPSTRA, W.; VAN DER GRIEND, R.; PRINS, M. H.; NIJZIEL, M. R.; VAN DE REE, M. A.; BÜLLER, H. R.; DUTILH, J. C.; TEN CATE-HOEK, A.; VAN DEN HEILIGENBERG, S. M.; VAN DER MEER, J.; OTTEN, J. M.

Favourites:
ADD

Free Content Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults
pp. 100-108(9)
Authors: MAUER, A. C.; KHAZANOV, N. A.; LEVENKOVA, N.; TIAN, S.; BARBOUR, E. M.; KHALIDA, C.; TOBIN, J. N.; COLLER, B. S.

Favourites:
ADD

Free Content Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment
pp. 109-118(10)
Authors: WATZKA, M.; GEISEN, C.; BEVANS, C. G.; SITTINGER, K.; SPOHN, G.; ROST, S.; SEIFRIED, E.; MÜLLER, C. R.; OLDENBURG, J.

Favourites:
ADD

Free Content Tissue factor pathway inhibitor and bacterial infection
pp. 119-121(3)
Authors: MARONEY, S. A.; MAST, A. E.

Favourites:
ADD

Free Content Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia
pp. 122-132(11)
Authors: VAN DEN BOOGAARD, F. E.; BRANDS, X.; SCHULTZ, M. J.; LEVI, M.; ROELOFS, J. J. T. H.; VAN 'T VEER, C.; VAN DER POLL, T.

Favourites:
ADD

Free Content Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
pp. 133-139(7)
Authors: HILLARP, A.; BAGHAEI, F.; FAGERBERG BLIXTER, I.; GUSTAFSSON, K. M.; STIGENDAL, L.; STEN-LINDER, M.; STRANDBERG, K.; LINDAHL, T. L.

Favourites:
ADD

Free Content An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies
pp. 149-153(5)
Authors: DE LAAT, B.; DERKSEN, R. H. W. M.; REBER, G.; MUSIAL, J.; SWADZBA, J.; BOZIC, B.; CUCNIK, S.; REGNAULT, V.; FORASTIERO, R.; WOODHAMS, B. J.; DE GROOT, PH. G.

Favourites:
ADD

Free Content The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood
pp. 154-162(9)
Authors: CARRIERI, C.; GALASSO, R.; SEMERARO, F.; AMMOLLO, C. T.; SEMERARO, N.; COLUCCI, M.

Favourites:
ADD

Free Content TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets
pp. 163-172(10)
Authors: ARTHUR, J. F.; SHEN, Y.; GARDINER, E. E.; COLEMAN, L.; KENNY, D.; ANDREWS, R. K.; BERNDT, M. C.

Favourites:
ADD

Free Content Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan
pp. 173-184(12)
Authors: ALEXANDRU, N.; POPOV, D.; DRAGAN, E.; ANDREI, E.; GEORGESCU, A.

Favourites:
ADD

Free Content Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease
pp. 185-191(7)
Authors: GROVE, E. L.; HVAS, A.M.; MORTENSEN, S. B.; LARSEN, S. B.; KRISTENSEN, S. D.

Favourites:
ADD
Favourites:
ADD

Free Content Human C-reactive protein enhances thrombus formation after neointimal balloon injury in transgenic rabbits
pp. 201-208(8)
Authors: MATSUDA, S.; YAMASHITA, A.; SATO, Y.; KITAJIMA, S.; KOIKE, T.; SUGITA, C.; MORIGUCHI-GOTO, S.; HATAKEYAMA, K.; TAKAHASHI, M.; KOSHIMOTO, C.; MATSUURA, Y.; IWAKIRI, T.; CHEN, Y. E.; FAN, J.; ASADA, Y.

Favourites:
ADD

Free Content CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment
pp. 209-219(11)
Authors: SARABI, A.; KRAMP, B. K.; DRECHSLER, M.; HACKENG, T. M.; SOEHNLEIN, O.; WEBER, C.; KOENEN, R. R.; VON HUNDELSHAUSEN, P.

Favourites:
ADD

Free Content Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas
pp. 220-222(3)
Authors: LEE, C. A.; HUBBARD, A.; SABIN, C. A.; BUDDE, U.; CASTAMAN, G.; FAVALORO, E. J.; FRIEDMAN, K. D.; FEDERICI, A. B.

Favourites:
ADD

Free Content Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy
pp. 223-226(4)
Authors: VAN AALDEREN, M. C.; TRAPPENBURG, M. C.; VAN SCHILFGAARDE, M.; MOLENAAR, P. J.; TEN CATE, H.; TERPSTRA, W. E.; LEYTE, A.

Favourites:
ADD

Free Content Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels
pp. 229-231(3)
Authors: MORANGE, P.-E.; SAUT, N.; ANTONI, G.; EMMERICH, J.; TRÉGOUËT, D.-A.

Favourites:
ADD
Favourites:
ADD

Free Content Thrombin generation is extremely sensitive to preheating conditions
pp. 233-234(2)
Authors: DE SMEDT, E.; HEMKER, H. C.

Favourites:
ADD

Free Content Join ISTH
pp. 235-236(2)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more